NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 4, Pages 102389
Publisher
Elsevier BV
Online
2021-04-01
DOI
10.1016/j.isci.2021.102389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY
- (2020) Jia‐Jia Cui et al. MASS SPECTROMETRY REVIEWS
- A genetic vaccine encoding shared cancer neoantigens to treat tumors with Microsatellite Instability.
- (2020) Guido Leoni et al. CANCER RESEARCH
- A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
- (2020) Matthias Kloor et al. CLINICAL CANCER RESEARCH
- UPF1-Mediated RNA Decay—Danse Macabre in a Cloud
- (2020) Daria Lavysh et al. Biomolecules
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
- (2020) Alexej Ballhausen et al. Nature Communications
- Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
- (2020) Vladimir Roudko et al. CELL
- Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
- (2019) Dyantha I. van der Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- FDA Approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors
- (2019) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
- (2019) Rupa Narayan et al. PLoS One
- Neoantigen quality, not quantity
- (2019) Nicholas McGranahan et al. Science Translational Medicine
- Divergent effects of translation termination factor eRF3A and nonsense-mediated mRNA decay factor UPF1 on the expression of uORF carrying mRNAs and ribosome protein genes
- (2019) Affaf Aliouat et al. RNA Biology
- Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
- (2018) Lena Katharina Freudenmann et al. IMMUNOLOGY
- A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes
- (2018) Renata Blatnik et al. PROTEOMICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
- (2018) A’dem Bokhari et al. Oncogenesis
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Rejection of immunogenic tumor clones is limited by clonal fraction
- (2018) Ron S Gejman et al. eLife
- In silicoand cell-based analyses reveal strong divergence between prediction and observation of T-cell–recognized tumor antigen T-cell epitopes
- (2017) Julien Schmidt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
- (2017) Chloe Chong et al. MOLECULAR & CELLULAR PROTEOMICS
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Building proteomic tool boxes to monitor MHC class I and class II peptides
- (2017) Frances-Rose Schumacher et al. PROTEOMICS
- Advantages of genome sequencing by long-read sequencer using SMRT technology in medical area
- (2017) Kazuma Nakano et al. Human Cell
- T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
- (2017) Else M. Inderberg et al. OncoImmunology
- Proteomic Analysis Reveals Branch-specific Regulation of the Unfolded Protein Response by Nonsense-mediated mRNA Decay
- (2016) Jana Sieber et al. MOLECULAR & CELLULAR PROTEOMICS
- The rules and impact of nonsense-mediated mRNA decay in human cancers
- (2016) Rik G H Lindeboom et al. NATURE GENETICS
- Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways
- (2016) Martino Colombo et al. RNA
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- (2015) Massimo Andreatta et al. BIOINFORMATICS
- The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy
- (2015) S. Walz et al. BLOOD
- Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
- (2015) Michal Bassani-Sternberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
- (2015) Jelle Scholtalbers et al. Genome Medicine
- 5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
- (2014) M. Bhuvanagiri et al. EMBO Molecular Medicine
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)
- (2014) G. P. M. Mommen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair
- (2013) P. J. Halvey et al. CANCER RESEARCH
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability
- (2012) Hidenori Tani et al. RNA Biology
- The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
- (2011) E. Caron et al. Molecular Systems Biology
- Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring
- (2011) Chor Teck Tan et al. PROTEOMICS
- Mechanism of escape from nonsense-mediated mRNA decay of human -globin transcripts with nonsense mutations in the first exon
- (2011) G. Neu-Yilik et al. RNA
- HLA class I supertypes: a revised and updated classification
- (2008) John Sidney et al. BMC IMMUNOLOGY
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Nonsense-Mediated mRNA Decay Impacts MSI-Driven Carcinogenesis and Anti-Tumor Immunity in Colorectal Cancers
- (2008) Jamila El-Bchiri et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation